Arcataur Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $666K | Hold |
1,496
| – | – | 0.21% | 46 |
|
|
2025
Q1 | $725K | Sell |
1,496
-158
| -10% | -$76.6K | 0.25% | 43 |
|
|
2024
Q4 | $666K | Hold |
1,654
| – | – | 0.22% | 43 |
|
|
2024
Q3 | $769K | Hold |
1,654
| – | – | 0.26% | 42 |
|
|
2024
Q2 | $775K | Sell |
1,654
-6
| -0.4% | -$2.81K | 0.28% | 38 |
|
|
2024
Q1 | $694K | Sell |
1,660
-615
| -27% | -$257K | 0.25% | 41 |
|
|
2023
Q4 | $926K | Sell |
2,275
-13
| -0.6% | -$5.29K | 0.35% | 29 |
|
|
2023
Q3 | $796K | Hold |
2,288
| – | – | 0.33% | 29 |
|
|
2023
Q2 | $805K | Buy |
+2,288
| New | +$805K | 0.33% | 30 |
|